Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens

doi:10.3389/fmicb.2022.975616

Editorial

. 2022 Jul 26:13:975616.

doi: 10.3389/fmicb.2022.975616. eCollection 2022.

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens

Payam Behzadi¹, Cecilia Ambrosi², Daniela Scribano³, Stefania Zanetti⁴, Meysam Sarshar⁵, Márió Gajdács⁶, Matthew Gavino Donadu^{4

7}

Affiliations

¹ Department of Microbiology, College of Basic Sciences, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran.
² Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Open University, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Rome, Italy.
³ Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
⁴ Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
⁵ Research Laboratories, Bambino Gesù Children's Hospital, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Rome, Italy.
⁶ Department of Oral Biology and Experimental Dental Research, Faculty of Dentistry, University of Szeged, Szeged, Hungary.
⁷ Hospital Pharmacy, Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy.

PMID: 35958138
PMCID: PMC9363151
DOI: 10.3389/fmicb.2022.975616

Editorial

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens

Payam Behzadi et al. Front Microbiol. 2022.

. 2022 Jul 26:13:975616.

doi: 10.3389/fmicb.2022.975616. eCollection 2022.

Authors

Payam Behzadi¹, Cecilia Ambrosi², Daniela Scribano³, Stefania Zanetti⁴, Meysam Sarshar⁵, Márió Gajdács⁶, Matthew Gavino Donadu^{4

7}

Affiliations

¹ Department of Microbiology, College of Basic Sciences, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran.
² Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Open University, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Rome, Italy.
³ Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
⁴ Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
⁵ Research Laboratories, Bambino Gesù Children's Hospital, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Rome, Italy.
⁶ Department of Oral Biology and Experimental Dental Research, Faculty of Dentistry, University of Szeged, Szeged, Hungary.
⁷ Hospital Pharmacy, Azienda Ospedaliero Universitaria di Sassari, Sassari, Italy.

PMID: 35958138
PMCID: PMC9363151
DOI: 10.3389/fmicb.2022.975616

No abstract available

Keywords: Pseudomonas aeruginosa; in vitro; infectious disease; multidrug resistance; quorum sensing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

Editorial on the Research Topic Current perspectives on Pseudomonas aeruginosa: Epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens

Cited by

Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy.
Fernández-Rubio B, Herrera-Hidalgo L, de Alarcón A, Luque-Márquez R, López-Cortés LE, Luque S, Gutiérrez-Urbón JM, Fernández-Polo A, Gutiérrez-Valencia A, Gil-Navarro MV. Fernández-Rubio B, et al. Pharmaceutics. 2023 Nov 30;15(12):2705. doi: 10.3390/pharmaceutics15122705. Pharmaceutics. 2023. PMID: 38140046 Free PMC article.
Understanding current challenges of antibiotic resistance to find new solutions for 2050: scientific, medical and political issues.
Georges RN, Doumèche B. Georges RN, et al. Arch Microbiol. 2025 May 29;207(7):162. doi: 10.1007/s00203-025-04340-0. Arch Microbiol. 2025. PMID: 40442329 Review.
Extensively drug-resistant Pseudomonas aeruginosa: clinical features and treatment with ceftazidime/avibactam and ceftolozane/tazobactam in a tertiary care university hospital center in Portugal - A cross-sectional and retrospective observational study.
Mendes Pedro D, Paulo SE, Santos CM, Fonseca AB, Melo Cristino J, Pereira ÁA, Caneiras C. Mendes Pedro D, et al. Front Microbiol. 2024 Feb 13;15:1347521. doi: 10.3389/fmicb.2024.1347521. eCollection 2024. Front Microbiol. 2024. PMID: 38414772 Free PMC article.
Impact of the 4th of August Beirut explosion mass casualty incident on a university hospital microbial Flora.
Roumieh Z, Mansour H, Assaad RA, Dimassi H, Husni R, Zoghby S, Mokhbat JE. Roumieh Z, et al. BMC Infect Dis. 2024 Jan 4;24(1):48. doi: 10.1186/s12879-023-08818-4. BMC Infect Dis. 2024. PMID: 38178025 Free PMC article.
Molecular epidemiology and carbapenem resistance mechanisms of Pseudomonas aeruginosa isolated from a hospital in Fujian, China.
Xie X, Liu Z, Huang J, Wang X, Tian Y, Xu P, Zheng G. Xie X, et al. Front Microbiol. 2024 Sep 5;15:1431154. doi: 10.3389/fmicb.2024.1431154. eCollection 2024. Front Microbiol. 2024. PMID: 39301190 Free PMC article.

See all "Cited by" articles

References

1. Behzadi P., Baráth Z., Gajdács M. (2021). It's not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa. Antibiotics. 10, 42. 10.3390/antibiotics10010042 - DOI - PMC - PubMed
1. Gajdács M., Baráth Z., Kárpáti K., Szabó D., Usai D., Zanetti S., et al. . (2021a). No correlation between biofilm formation, virulence factors, and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study. Antibiotics 10, e1134. 10.3390/antibiotics10091134 - DOI - PMC - PubMed
1. Gajdács M., Urbán E., Stájer A., Baráth Z. (2021b). Antimicrobial resistance in the context of the sustainable development goals: a brief review. Eur. J. Invest. Health Psychol. Educ. 11, 71–82. 10.3390/ejihpe11010006 - DOI - PMC - PubMed
1. McGowan J. E.. (2006). Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am. J. Med. 119, S29–S36. 10.1016/j.amjmed.03014 - DOI - PubMed
1. Oren A., Garrity G. M. (2021). Valid publication of the names of forty-two phyla of prokaryotes. Int. J. Syst. Evolutionary Microbiol. 71, 5056. 10.1099./ijsem.0.005056 - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Behzadi P., Baráth Z., Gajdács M. (2021). It's not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa. Antibiotics. 10, 42. 10.3390/antibiotics10010042 - DOI - PMC - PubMed

[2] Behzadi P., Baráth Z., Gajdács M. (2021). It's not easy being green: a narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa. Antibiotics. 10, 42. 10.3390/antibiotics10010042 - DOI - PMC - PubMed

[3] Gajdács M., Baráth Z., Kárpáti K., Szabó D., Usai D., Zanetti S., et al. . (2021a). No correlation between biofilm formation, virulence factors, and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study. Antibiotics 10, e1134. 10.3390/antibiotics10091134 - DOI - PMC - PubMed

[4] Gajdács M., Baráth Z., Kárpáti K., Szabó D., Usai D., Zanetti S., et al. . (2021a). No correlation between biofilm formation, virulence factors, and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study. Antibiotics 10, e1134. 10.3390/antibiotics10091134 - DOI - PMC - PubMed

[5] Gajdács M., Urbán E., Stájer A., Baráth Z. (2021b). Antimicrobial resistance in the context of the sustainable development goals: a brief review. Eur. J. Invest. Health Psychol. Educ. 11, 71–82. 10.3390/ejihpe11010006 - DOI - PMC - PubMed

[6] Gajdács M., Urbán E., Stájer A., Baráth Z. (2021b). Antimicrobial resistance in the context of the sustainable development goals: a brief review. Eur. J. Invest. Health Psychol. Educ. 11, 71–82. 10.3390/ejihpe11010006 - DOI - PMC - PubMed

[7] McGowan J. E.. (2006). Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am. J. Med. 119, S29–S36. 10.1016/j.amjmed.03014 - DOI - PubMed

[8] McGowan J. E.. (2006). Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am. J. Med. 119, S29–S36. 10.1016/j.amjmed.03014 - DOI - PubMed

[9] Oren A., Garrity G. M. (2021). Valid publication of the names of forty-two phyla of prokaryotes. Int. J. Syst. Evolutionary Microbiol. 71, 5056. 10.1099./ijsem.0.005056 - DOI - PubMed

[10] Oren A., Garrity G. M. (2021). Valid publication of the names of forty-two phyla of prokaryotes. Int. J. Syst. Evolutionary Microbiol. 71, 5056. 10.1099./ijsem.0.005056 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens

Affiliations

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources